Ann: AGM Chair's address and CEO's presentation, page-17

Yes it all sounds a little 'unusual' .... Starpharma is becoming a laughing stock with the comedy of errors / change in direction and don't even get me started with the 'moving of guidance goalposts' .... Cheryl seems no different to the last CEO in this respect having now moved the original 9 month deadline for a DEP license deal out by another 9 months (18 months in total with the new 12 month guideline announced recently)


@antibotter you seem awfully quiet about everything ? .... and all of the supposed buyers of millions of shares also seem somewhat quiet - perhaps things aren't as positive as they once believed they were at Abbottsford ?


I would also imagine anyone can now change their vote in Computershare while we wait until Friday if they want to .... mine were a NO anyway but some that voted yes may feel inclined to change those votes to a NO now; especially with the 'overnight' nonsense about AstraZeneca embedded deep in the presentation ?


The only DEP partnership deal that saw Starpharma receive any upfront payment and a $5 million milestone payment is now officially terminated .... Merck and Genentech must be laughing knowing that they get to look at everything they want for free through IMO desperate / poor contractual negotiations by Starpharma and subsequently seeing their biggest competitor for DEP in the inner circle officially leaving the building